CY1119762T1 - C-17-ετεροαρυλικα παραγωγα ελαιολικου οξεος και μεθοδοι χρησης αυτων - Google Patents
C-17-ετεροαρυλικα παραγωγα ελαιολικου οξεος και μεθοδοι χρησης αυτωνInfo
- Publication number
- CY1119762T1 CY1119762T1 CY20171101157T CY171101157T CY1119762T1 CY 1119762 T1 CY1119762 T1 CY 1119762T1 CY 20171101157 T CY20171101157 T CY 20171101157T CY 171101157 T CY171101157 T CY 171101157T CY 1119762 T1 CY1119762 T1 CY 1119762T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- oleic acid
- hetero
- aryl derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epidemiology (AREA)
- Lubricants (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261699199P | 2012-09-10 | 2012-09-10 | |
| PCT/US2013/059015 WO2014040056A1 (en) | 2012-09-10 | 2013-09-10 | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119762T1 true CY1119762T1 (el) | 2018-06-27 |
Family
ID=49253401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171101157T CY1119762T1 (el) | 2012-09-10 | 2017-11-03 | C-17-ετεροαρυλικα παραγωγα ελαιολικου οξεος και μεθοδοι χρησης αυτων |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20140088163A1 (OSRAM) |
| EP (1) | EP2892911B1 (OSRAM) |
| JP (1) | JP6272870B2 (OSRAM) |
| KR (1) | KR102237364B1 (OSRAM) |
| CN (1) | CN104768965B (OSRAM) |
| AU (1) | AU2013312102B2 (OSRAM) |
| BR (1) | BR112015005200B1 (OSRAM) |
| CA (1) | CA2882417C (OSRAM) |
| CY (1) | CY1119762T1 (OSRAM) |
| DK (1) | DK2892911T3 (OSRAM) |
| EA (1) | EA029069B1 (OSRAM) |
| ES (1) | ES2644615T3 (OSRAM) |
| HR (1) | HRP20171565T1 (OSRAM) |
| HU (1) | HUE036797T2 (OSRAM) |
| IL (1) | IL237638B (OSRAM) |
| IN (1) | IN2015DN01547A (OSRAM) |
| LT (1) | LT2892911T (OSRAM) |
| ME (1) | ME02911B (OSRAM) |
| MX (1) | MX366954B (OSRAM) |
| NZ (1) | NZ705213A (OSRAM) |
| PL (1) | PL2892911T3 (OSRAM) |
| PT (1) | PT2892911T (OSRAM) |
| RS (1) | RS56563B1 (OSRAM) |
| SG (1) | SG11201501800UA (OSRAM) |
| SI (1) | SI2892911T1 (OSRAM) |
| SM (1) | SMT201700501T1 (OSRAM) |
| WO (1) | WO2014040056A1 (OSRAM) |
| ZA (1) | ZA201501203B (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2252283T (pt) | 2008-01-11 | 2019-01-23 | Reata Pharmaceuticals Inc | Triterpenóides sintéticos e métodos de uso no tratamento de doença |
| NZ588708A (en) | 2008-04-18 | 2012-09-28 | Reata Pharmaceuticals Inc | 2-cyano steroid derivatives including an anti-inflammatory pharmacore |
| US8124799B2 (en) | 2008-04-18 | 2012-02-28 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 |
| NO2651902T3 (OSRAM) | 2010-12-17 | 2018-04-07 | ||
| EP2841445B1 (en) | 2012-04-27 | 2017-06-14 | Reata Pharmaceuticals, Inc. | 2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof |
| WO2013188818A1 (en) | 2012-06-15 | 2013-12-19 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| CN104955833B (zh) | 2012-09-10 | 2019-10-11 | 里亚塔医药公司 | 齐墩果酸的c17-烷二基与烯二基衍生物及其使用方法 |
| UY35534A (es) | 2013-04-24 | 2014-10-31 | Abbvie Inc | Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso |
| CA2974726C (en) | 2015-02-12 | 2023-09-19 | Reata Pharmaceuticals, Inc. | Imidazolyl tricyclic enones as antioxidant inflammation modulators |
| BR112018005861B1 (pt) | 2015-09-23 | 2022-11-22 | Reata Pharmaceuticals, Inc | Compostos derivados de ácido oleanólico modificado com c4 para a inibição de il-17, composição farmacêutica e usos terapêuticos dos ditos compostos |
| MA46749A (fr) | 2016-11-08 | 2019-09-18 | Reata Pharmaceuticals Inc | Méthodes de traitement du syndrome d'alport à l'aide d'un méthyle de bardoxolone ou d'analogues de ce dernier |
| CN106632574B (zh) * | 2016-12-07 | 2018-05-29 | 广东天键生物科技有限公司 | 一种化合物、其制备方法及用途 |
| TWI831738B (zh) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
| CA3075729A1 (en) | 2017-09-14 | 2019-03-21 | Phoenix Biotechnology, Inc. | Use of oleandrin to treatn viral infection |
| RU2758376C2 (ru) | 2017-09-14 | 2021-10-28 | Феникс Байотекнолоджи, Инк. | Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний |
| EP3807265A1 (en) | 2018-06-15 | 2021-04-21 | Reata Pharmaceuticals, Inc. | Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma |
| WO2019246461A1 (en) | 2018-06-20 | 2019-12-26 | Reata Pharmaceuticals, Inc. | Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith |
| EP3856755A4 (en) * | 2018-09-28 | 2022-12-28 | Sichuan Haisco Pharmaceutical Co., Ltd. | Terpinoid derivatives and uses thereof |
| TWI861163B (zh) * | 2019-07-19 | 2024-11-11 | 美商瑞塔醫藥有限責任公司 | C17經極性取代之雜芳合成三萜類化合物及其使用方法 |
| KR102464428B1 (ko) | 2020-03-31 | 2022-11-04 | 피닉스 바이오테크놀러지 인코포레이티드. | 코로나바이러스 감염 치료를 위한 방법 및 조성물 |
| EP4295854A3 (en) | 2020-03-31 | 2024-04-03 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
| JP7214696B2 (ja) * | 2020-10-01 | 2023-01-30 | 一般財団法人 化学物質評価研究機構 | 新規ｉｎ ｖｉｔｒｏ皮膚感作性試験法 |
| AU2021397631A1 (en) | 2020-12-11 | 2023-07-20 | Reata Pharmaceuticals Holdings, LLC | Synthetic triterpenoids for use in therapy |
| CN117015548A (zh) | 2021-01-18 | 2023-11-07 | 里亚塔医药公司 | 合成的熊果酸衍生物和其使用方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| EP1507541A4 (en) * | 2002-05-13 | 2009-06-03 | Dartmouth College | HEMMER AND APPLICATION METHOD THEREFOR |
| PT2252283T (pt) | 2008-01-11 | 2019-01-23 | Reata Pharmaceuticals Inc | Triterpenóides sintéticos e métodos de uso no tratamento de doença |
| CA2721666C (en) * | 2008-04-18 | 2017-05-23 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
| US8124799B2 (en) * | 2008-04-18 | 2012-02-28 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 |
| NZ588709A (en) * | 2008-04-18 | 2012-11-30 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: triterpenoid oleanolic acid derivatives with saturation in the c-ring |
| TW201004627A (en) | 2008-04-18 | 2010-02-01 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| UY33946A (es) * | 2011-03-11 | 2012-08-31 | Reata Pharmaceuticals Inc | Derivados de c4-monometil triterpenoides y sus métodos de uso |
| WO2013188818A1 (en) * | 2012-06-15 | 2013-12-19 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
-
2013
- 2013-09-10 AU AU2013312102A patent/AU2013312102B2/en active Active
- 2013-09-10 SI SI201330818T patent/SI2892911T1/sl unknown
- 2013-09-10 LT LTEP13767175.6T patent/LT2892911T/lt unknown
- 2013-09-10 CN CN201380057684.2A patent/CN104768965B/zh active Active
- 2013-09-10 KR KR1020157009160A patent/KR102237364B1/ko active Active
- 2013-09-10 HR HRP20171565TT patent/HRP20171565T1/hr unknown
- 2013-09-10 BR BR112015005200-2A patent/BR112015005200B1/pt active IP Right Grant
- 2013-09-10 NZ NZ705213A patent/NZ705213A/en unknown
- 2013-09-10 JP JP2015531317A patent/JP6272870B2/ja active Active
- 2013-09-10 PT PT137671756T patent/PT2892911T/pt unknown
- 2013-09-10 ME MEP-2017-254A patent/ME02911B/me unknown
- 2013-09-10 RS RS20171140A patent/RS56563B1/sr unknown
- 2013-09-10 EP EP13767175.6A patent/EP2892911B1/en active Active
- 2013-09-10 PL PL13767175T patent/PL2892911T3/pl unknown
- 2013-09-10 EA EA201590539A patent/EA029069B1/ru unknown
- 2013-09-10 US US14/022,843 patent/US20140088163A1/en not_active Abandoned
- 2013-09-10 MX MX2015003078A patent/MX366954B/es active IP Right Grant
- 2013-09-10 DK DK13767175.6T patent/DK2892911T3/en active
- 2013-09-10 SG SG11201501800UA patent/SG11201501800UA/en unknown
- 2013-09-10 WO PCT/US2013/059015 patent/WO2014040056A1/en not_active Ceased
- 2013-09-10 IN IN1547DEN2015 patent/IN2015DN01547A/en unknown
- 2013-09-10 CA CA2882417A patent/CA2882417C/en active Active
- 2013-09-10 HU HUE13767175A patent/HUE036797T2/hu unknown
- 2013-09-10 SM SM20170501T patent/SMT201700501T1/it unknown
- 2013-09-10 ES ES13767175.6T patent/ES2644615T3/es active Active
-
2015
- 2015-02-23 ZA ZA2015/01203A patent/ZA201501203B/en unknown
- 2015-03-09 IL IL237638A patent/IL237638B/en active IP Right Grant
-
2017
- 2017-11-03 CY CY20171101157T patent/CY1119762T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119762T1 (el) | C-17-ετεροαρυλικα παραγωγα ελαιολικου οξεος και μεθοδοι χρησης αυτων | |
| CY1121776T1 (el) | C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων | |
| CY1121744T1 (el) | Παραγωγα c4-μονομεθυλο-τριτερπενοειδους και μεθοδοι χρησης αυτων | |
| CY1120032T1 (el) | Πυραζολυλικες και πυριμιδιυλικες τρικυκλικες ενονες ως αντιοξειδωτικοι ρυθμιστες φλεγμονης | |
| CY1119060T1 (el) | Ρυθμιστες ενζυμων μεθυλικης τροποποιησης, συνθεσεις και χρησεις αυτων | |
| CY1118869T1 (el) | Παραγωγα αμιδο σπειροκυκλικου αμιδιου και σουλφοναμιδιου | |
| CL2018003323A1 (es) | Piridinas sustituidas con heteroarilo y métodos de uso. | |
| CY1115945T1 (el) | Παραγωγα πυραζολοκινολινονης, η παρασκευη τους και η θεραπευτικη τους χρηση | |
| CY1118860T1 (el) | Νεα διαζασπειροκυκλοαλκανια και αζασπειροκυκλοαλκανια | |
| CY1119953T1 (el) | Yποκατεστημενες πυριδοπυραζινες ως προτυποι syk ανοστολεις | |
| UY34104A (es) | ?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?. | |
| UY35467A (es) | Compuestos orgánicos | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| UY35643A (es) | Nuevos compuestos útiles como nematicidas, sus composiciones y métodos de uso | |
| UY34578A (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas q ue los contienen | |
| CY1117105T1 (el) | Ενωσεις πυριδαζινονης και χρηση τους ως αναστολεις του daao | |
| CU20140081A7 (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| TR201900038T4 (tr) | GPR6'nın tetrahidropiridopirazin modülatörleri. | |
| CY1111367T1 (el) | Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| CY1118371T1 (el) | Αναστολεις του iap | |
| CY1120133T1 (el) | Πυριδαζινονες ως αναστολεις ενζυμου daao | |
| CY1117396T1 (el) | Υποκατεστημενες 4,5,6,7-τετραϋδρο-1η-πυραζολο[4,3-c]πυριδινες, η χρηση αυτων ως φαρμακο, και φαρμακευτικα παρασκευασματα που τις περιεχουν | |
| UY34314A (es) | Derivados de anilina, su preparación y su aplicación terapéutica. | |
| UY33874A (es) | Derivados de ácido 3-heteroaroilamino-propiónico sustituidos y su uso como sustancias farmacéuticas | |
| CY1123744T1 (el) | Παραγωγα πυριδινυλιου, φαρμακευτικες συνθεσεις και χρησεις αυτων ως αναστολεων aoc3 |